Fundraising Fox

Menlo Therapeutics

Menlo Park, US · Delaware corporation · 1 known investors

Biotech

Founders & leadership

SL
Steven L. BastaExecutive
JC
John CreecyNamed on SEC filing
SW
Scott WhitcupNamed on SEC filing
TE
Ted EbelNamed on SEC filing
KP
Ketan PatelNamed on SEC filing
DC
David CollierNamed on SEC filing

Board

AC
Albert ChaBoard director
ARAaron Royston
Aaron Roystonin𝕏Board directorManaging Partner at venBio Partners

Investors · 1

venBio PartnersreportedSan Franciscovia Aaron Royston · board

Reported raises · per SEC filings

Form D private placements

$139M disclosed across 3 rounds · 2017–2023

▶$88.2MraisedNov 2023 · 19 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • SHARON BARBARIDirector
  • MUTYA HARSCHExecutive Officer
  • TYLER ZERONDAExecutive Officer
  • DAVID DOMZALSKIExecutive Officer, Director
  • ELISABETH SANDOVALDirector
  • PATRICK LEPOREDirector
  • STEVEN BASTADirector
  • IAIN STUARTExecutive Officer
  • ANTHONY BRUNODirector
Offering amount
$88.2M
Amount sold
$88.2M
Sales commissions
$5M
Placement agents
LifeSci Capital LLC
First sale
Nov 2023
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$300KraisedNov 2022 · 1 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • ANTHONY BRUNODirector
  • PATRICK LEPOREDirector
  • IAIN STUARTExecutive Officer
  • STEVEN BASTADirector
  • ELISABETH SANDOVALDirector
  • DAVID DOMZALSKIExecutive Officer, Director
  • TYLER ZERONDAExecutive Officer
  • MUTYA HARSCHExecutive Officer
  • SHARON BARBARIDirector
Offering amount
$300K
Amount sold
$300K
First sale
Nov 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$50.5MraisedJul 2017 · 11 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Albert ChaDirector
  • Steven L. BastaExecutive Officer, Director
  • John CreecyDirector
  • Scott WhitcupDirector
  • Aaron RoystonDirector
  • Ted EbelDirector
  • Ketan PatelDirector
  • David CollierDirector
Offering amount
$50.5M
Amount sold
$50.5M
First sale
Jul 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

Who are Menlo Therapeutics's investors?
Menlo Therapeutics's investors include venBio Partners.
How much funding has Menlo Therapeutics raised?
Menlo Therapeutics has disclosed $139M raised across 3 rounds.
Where is Menlo Therapeutics headquartered?
Menlo Therapeutics is headquartered in Menlo Park, US.